$EXEL
EXELIXIS, INC.

2020 Q4 Form 10-Q Financial Statement

#000093976720000150 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q3 2019 Q2
Revenue $231.1M $271.7M $240.3M
YoY Change -3.83% 20.54% 29.11%
Cost Of Revenue $8.725M $7.537M $7.539M
YoY Change -16.9% 2.4% 25.71%
Gross Profit $159.9M $184.2M $186.1M
YoY Change -30.43% 18.41% 33.11%
Gross Profit Margin 69.18% 67.81% 77.47%
Selling, General & Admin $88.19M $51.27M $58.82M
YoY Change 52.04% 6.54% 13.43%
% of Gross Profit 55.16% 27.83% 31.6%
Research & Development $176.8M $97.30M $81.93M
YoY Change 87.25% 117.46% 92.84%
% of Gross Profit 110.57% 52.81% 44.02%
Depreciation & Amortization $2.400M $2.100M $2.000M
YoY Change 9.09% 23.53% 150.0%
% of Gross Profit 1.5% 1.14% 1.07%
Operating Expenses $264.9M $156.1M $148.3M
YoY Change 73.74% 55.75% 47.79%
Operating Profit -$42.58M $115.6M $91.99M
YoY Change -155.08% -7.65% 7.25%
Interest Expense $3.500M $7.200M $7.000M
YoY Change -54.55% 719900.0%
% of Operating Profit 6.23% 7.61%
Other Income/Expense, Net $565.0K $7.051M $7.778M
YoY Change 86.63% 196.3%
Pretax Income -$38.02M $122.7M $99.77M
YoY Change -144.73% -4.88% 12.86%
Income Tax -$5.981M $25.21M $20.73M
% Of Pretax Income 20.55% 20.77%
Net Earnings -$32.04M $97.45M $79.04M
YoY Change -146.64% -23.04% -9.66%
Net Earnings / Revenue -13.86% 35.87% 32.9%
Basic Earnings Per Share -$0.10 $0.32 $0.26
Diluted Earnings Per Share -$0.10 $0.31 $0.25
COMMON SHARES
Basic Shares Outstanding 309.1M shares 303.3M shares 302.2M shares
Diluted Shares Outstanding 309.1M shares 315.5M shares 314.9M shares

Balance Sheet

Concept 2020 Q4 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.207B $760.7M $822.1M
YoY Change 41.57% 19.87% 64.45%
Cash & Equivalents $334.0M $242.3M $369.8M
Short-Term Investments $887.3M $518.4M $452.3M
Other Short-Term Assets $57.00M $14.50M $12.80M
YoY Change 111.11% 13.28% 18.52%
Inventory $19.32M $13.37M $12.35M
Prepaid Expenses
Receivables $160.9M $169.8M $97.50M
Other Receivables $0.00 $13.80M $12.39M
Total Short-Term Assets $1.408B $972.1M $957.2M
YoY Change 39.22% 23.53% 39.48%
LONG-TERM ASSETS
Property, Plant & Equipment $56.39M $49.47M $50.71M
YoY Change 15.31% -3.09% -21.68%
Goodwill $63.68M $63.68M $63.68M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $332.3M $486.8M $337.8M
YoY Change -38.05% 326.64% 257.84%
Other Assets $69.41M $7.268M $5.763M
YoY Change -69.22% 387.13% 507.91%
Total Long-Term Assets $703.2M $812.8M $685.9M
YoY Change -19.58% 242.35% 205.0%
TOTAL ASSETS
Total Short-Term Assets $1.408B $972.1M $957.2M
Total Long-Term Assets $703.2M $812.8M $685.9M
Total Assets $2.111B $1.785B $1.643B
YoY Change 11.95% 74.24% 80.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $47.93M $8.352M $12.27M
YoY Change 313.16% -3.77% -5.75%
Accrued Expenses $115.9M $72.70M $58.40M
YoY Change 27.78% 3.12% -16.33%
Deferred Revenue $1.300M $321.0K
YoY Change -94.6%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K
YoY Change
Total Short-Term Liabilities $201.3M $141.1M $110.8M
YoY Change 41.1% 55.18% 10.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -99.51%
Other Long-Term Liabilities $721.0K $975.0K $4.495M
YoY Change -98.74% -62.6% 23.83%
Total Long-Term Liabilities $721.0K $975.0K $4.495M
YoY Change -98.74% -62.6% 23.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $201.3M $141.1M $110.8M
Total Long-Term Liabilities $721.0K $975.0K $4.495M
Total Liabilities $259.0M $181.1M $154.5M
YoY Change 29.7% 67.11% 13.42%
SHAREHOLDERS EQUITY
Retained Earnings -$476.0M -$628.1M -$725.5M
YoY Change -49.37% -46.94%
Common Stock $309.0K $304.0K $303.0K
YoY Change 1.67% 1.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.852B $1.604B $1.489B
YoY Change
Total Liabilities & Shareholders Equity $2.111B $1.785B $1.643B
YoY Change 11.95% 74.24% 80.33%

Cashflow Statement

Concept 2020 Q4 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$32.04M $97.45M $79.04M
YoY Change -146.64% -23.04% -9.66%
Depreciation, Depletion And Amortization $2.400M $2.100M $2.000M
YoY Change 9.09% 23.53% 150.0%
Cash From Operating Activities $33.30M $75.60M $131.7M
YoY Change -78.94% -54.13% 76.78%
INVESTING ACTIVITIES
Capital Expenditures -$14.20M -$2.100M -$1.200M
YoY Change 97.22% -86.18% -90.24%
Acquisitions
YoY Change
Other Investing Activities -$15.20M -$204.4M -$141.7M
YoY Change -87.63% 325.83% 162.41%
Cash From Investing Activities -$29.50M -$206.4M -$142.9M
YoY Change -77.34% 226.07% 115.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.70M 3.300M 7.100M
YoY Change 523.33% -8.33% -5.33%
NET CHANGE
Cash From Operating Activities 33.30M 75.60M 131.7M
Cash From Investing Activities -29.50M -206.4M -142.9M
Cash From Financing Activities -18.70M 3.300M 7.100M
Net Change In Cash -14.90M -127.5M -4.100M
YoY Change -159.84% -221.31% -126.11%
FREE CASH FLOW
Cash From Operating Activities $33.30M $75.60M $131.7M
Capital Expenditures -$14.20M -$2.100M -$1.200M
Free Cash Flow $47.50M $77.70M $132.9M
YoY Change -71.26% -56.83% 53.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000939767
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-10-02
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity File Number
EntityFileNumber
000-30235
dei Entity Registrant Name
EntityRegistrantName
EXELIXIS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3257395
dei Entity Address Address Line1
EntityAddressAddressLine1
1851 Harbor Bay Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Alameda,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94502
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
837-7000
dei Security12b Title
Security12bTitle
Common Stock $.001 Par Value per Share
dei Trading Symbol
TradingSymbol
EXEL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
310243961 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
334046000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266501000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
853835000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
585742000 USD
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
166138000 USD
CY2020Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
119073000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
19319000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
12886000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34470000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26988000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1407808000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1011190000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
358079000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
536385000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56385000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48892000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
155678000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
172374000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
63684000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
63684000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69409000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53145000 USD
CY2020Q4 us-gaap Assets
Assets
2111043000 USD
CY2020Q1 us-gaap Assets
Assets
1885670000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
47927000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11581000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
40782000 USD
CY2020Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
37364000 USD
CY2020Q4 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
47074000 USD
CY2020Q1 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
38777000 USD
CY2020Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
19129000 USD
CY2020Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
18719000 USD
CY2020Q4 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
11102000 USD
CY2020Q1 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
11856000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35329000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24449000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
201343000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
142746000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9322000 USD
CY2020Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6596000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47626000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48011000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
721000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2347000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
259012000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
199700000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
309402000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
309402000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
304831000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
304831000 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
309000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
305000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2321441000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2241947000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6239000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3069000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-475958000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-559351000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1852031000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1685970000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2111043000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1885670000 USD
CY2020Q4 us-gaap Revenues
Revenues
231092000 USD
CY2019Q3 us-gaap Revenues
Revenues
271703000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
313095000 USD
us-gaap Revenues
Revenues
717486000 USD
us-gaap Revenues
Revenues
727465000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8725000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7537000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27235000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22577000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
176762000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97295000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
393572000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
242516000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88185000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51265000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
210916000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
170218000 USD
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
273672000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
156097000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
102710000 USD
us-gaap Costs And Expenses
CostsAndExpenses
631723000 USD
us-gaap Costs And Expenses
CostsAndExpenses
435311000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-42580000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
115606000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
85763000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
292154000 USD
CY2020Q4 us-gaap Interest Income Other
InterestIncomeOther
3994000 USD
CY2019Q3 us-gaap Interest Income Other
InterestIncomeOther
7191000 USD
us-gaap Interest Income Other
InterestIncomeOther
16376000 USD
us-gaap Interest Income Other
InterestIncomeOther
20253000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
565000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-140000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
571000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
688000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38021000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
122657000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5981000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25205000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19317000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60826000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309116000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303268000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
307437000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301999000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
309116000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315453000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
317495000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315046000 shares
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
453000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-129000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-893000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-936000 USD
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1601000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
461000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3170000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3369000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33641000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
97913000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
86563000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
255638000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1833324000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1601000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1872000 USD
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5179000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55655000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1852031000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1488632000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
461000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4968000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
935000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13139000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1603717000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1685970000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3170000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19827000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26120000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85791000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1852031000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1287453000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3369000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23248000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3369000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40747000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1603717000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6731000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6088000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
85791000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
40747000 USD
exel Noncash Lease Expense
NoncashLeaseExpense
3607000 USD
exel Noncash Lease Expense
NoncashLeaseExpense
1803000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
15803000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
56339000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1609000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
621000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47074000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7017000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13466000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3528000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15868000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14108000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4012000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3592000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
51151000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
33371000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
175689000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
368935000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16055000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5575000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
866975000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
887698000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
781324000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
436227000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101706000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-457046000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
19682000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18956000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26120000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3369000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-34000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6438000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15553000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
67545000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-72558000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268137000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
315875000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335682000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243317000 USD
exel Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
1824000 USD
exel Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
12944000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
843000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
159000 USD
exel Liabilities Expenditures Incurred But Not Yet Paid To Related Party Transactions
LiabilitiesExpendituresIncurredButNotYetPaidToRelatedPartyTransactions
0 USD
exel Liabilities Expenditures Incurred But Not Yet Paid To Related Party Transactions
LiabilitiesExpendituresIncurredButNotYetPaidToRelatedPartyTransactions
8961000 USD
us-gaap Fiscal Period
FiscalPeriod
<span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a 52- or 53-week fiscal year policy that generally ends on the Friday closest to December 31</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Fiscal year 2020, which is a 52-week fiscal year, will end on January 1, 2021 and fiscal year 2019, which was a 53-week fiscal year, ended on January 3, 2020. For convenience, references in this report as of and for the fiscal periods ended October 2, 2020 and September 27, 2019, and as of and for the fiscal years ending January 1, 2021, and ended January 3, 2020, are indicated as being as of and for the fiscal periods ended September 30, 2020 and September 30, 2019 and the years ending </span>December 31, 2020 and ended December 31, 2019, respectively. Similarly, references in this report to the first day of the fiscal year ending January 1, 2021 are indicated as being as of January 1, 2020.
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain prior period amounts in the accompanying Condensed Consolidated Financial Statements have been reclassified to conform to the current period presentation. Such reclassifications did not impact previously reported total revenues, income from operations, net income, total assets, total liabilities or total stockholders’ equity.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the accompanying Condensed Consolidated Financial Statements conforms to accounting principles generally accepted in the U.S., which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.In March 2020, we received the Preliminary Calculation of our Branded Prescription Drug Fee for 2020, and in August 2020, the Final Calculation of our Branded Prescription Drug Fee for 2020 from the Internal Revenue Service for the 2018 sales year, which resulted in an increase in our estimate of such fees for the 2018 and 2019 sales years.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q4 us-gaap Revenues
Revenues
231092000 USD
CY2019Q3 us-gaap Revenues
Revenues
271703000 USD
us-gaap Revenues
Revenues
717486000 USD
us-gaap Revenues
Revenues
727465000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
231092000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
271703000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
717486000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
727465000 USD
CY2020Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
26233000 USD
exel Valuation Allowances And Reserves Additions For Sales In Current Period
ValuationAllowancesAndReservesAdditionsForSalesInCurrentPeriod
161235000 USD
exel Valuation Allowances And Reserves Additions For Sales In Prior Period
ValuationAllowancesAndReservesAdditionsForSalesInPriorPeriod
433000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
160177000 USD
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
27724000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 USD
CY2020Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1100000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10600000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6600000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1300000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6800000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2700000 USD
CY2020Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
33100000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
115300000 USD
CY2019Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
67700000 USD
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
129000000.0 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
88900000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
334046000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266501000 USD
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1636000 USD
CY2020Q1 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1636000 USD
CY2020Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335682000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268137000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1329225000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8210000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1337405000 USD
CY2020Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1537779000 USD
CY2020Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8211000 USD
CY2020Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000 USD
CY2020Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1545960000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1308351000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4121000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1312464000 USD
CY2020Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1384510000 USD
CY2020Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4126000 USD
CY2020Q1 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1388628000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
4500000 USD
CY2020Q1 us-gaap Interest Receivable
InterestReceivable
6200000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
100092000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
30000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
17377000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
8000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
16 investment
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
9 investment
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
993211000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
789913000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
344194000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
522551000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1337405000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1312464000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5298000 USD
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
2709000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
17911000 USD
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
9447000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4535000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4367000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
27744000 USD
CY2020Q1 us-gaap Inventory Gross
InventoryGross
16523000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
27744000 USD
CY2020Q1 us-gaap Inventory Gross
InventoryGross
16523000 USD
us-gaap Inventory Write Down
InventoryWriteDown
2200000 USD
us-gaap Inventory Write Down
InventoryWriteDown
400000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55655000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13139000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85791000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40747000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
16900406 shares
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Stock Option Or Stock Appreciation Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToStockOptionOrStockAppreciationAward
1 shares
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Other Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToOtherAwards
1.5 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
21000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1189888 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.61
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16219326 shares
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.157
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.188
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.194
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32040000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
97452000 USD
us-gaap Net Income Loss
NetIncomeLoss
83393000 USD
us-gaap Net Income Loss
NetIncomeLoss
252269000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309116000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303268000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
307437000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301999000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12185000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10058000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13047000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
309116000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315453000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
317495000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
315046000 shares
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80

Files In Submission

Name View Source Status
0000939767-20-000150-index-headers.html Edgar Link pending
0000939767-20-000150-index.html Edgar Link pending
0000939767-20-000150.txt Edgar Link pending
0000939767-20-000150-xbrl.zip Edgar Link pending
exel-20201002.htm Edgar Link pending
exel-20201002.xsd Edgar Link pending
exel-20201002_cal.xml Edgar Link unprocessable
exel-20201002_def.xml Edgar Link unprocessable
exel-20201002_g1.jpg Edgar Link pending
exel-20201002_htm.xml Edgar Link completed
exel-20201002_lab.xml Edgar Link unprocessable
exel-20201002_pre.xml Edgar Link unprocessable
exel20200930exhibit101.htm Edgar Link pending
exel20200930exhibit311.htm Edgar Link pending
exel20200930exhibit312.htm Edgar Link pending
exel20200930exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending